Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (HK:2185) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Bio-Heart Biological Technology Co., Ltd. has announced the composition of its Board of Directors, which includes Executive Directors Philip Li WANG, Yunqing WANG, and Peili WANG, alongside Independent Non-executive Directors Yiqing CHEN, Xubo LU, and Yifei JIANG. The company also outlined the structure of its three key Board committees – Audit, Remuneration, and Nomination – detailing the chairpersons and members of each.
For further insights into HK:2185 stock, check out TipRanks’ Stock Analysis page.